1 / 5

Suppl Fig 1

Suppl Fig 1. Heidelberg 2005-2013: Chronic GVHD over time in all patients available for GVL response pattern analysis (n=60, -> excluding patients with non-engraftment, death <120d, or rel <120d). Suppl Fig 2. Impact of start of IS taper on outcome. REL. NRM. Suppl Fig 3.

blarkin
Download Presentation

Suppl Fig 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Suppl Fig 1 Heidelberg 2005-2013:Chronic GVHD over time in all patients available for GVL response pattern analysis (n=60, -> excluding patients with non-engraftment, death <120d, or rel <120d)

  2. Suppl Fig 2 Impact of start of IS taper on outcome REL NRM

  3. Suppl Fig 3 Impact of status on outcome REL NRM PFS OS

  4. Suppl Fig 4 Impact of conditioning on outcome REL NRM PFS OS

  5. Suppl Fig 5 Impact of EBMT risk on outcome NRM REL PFS OS n.s.

More Related